rs1800095

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 1P and 9B. PP3BP6BS1BS2

The NM_000492.4(CFTR):​c.1584G>A​(p.Glu528Glu) variant causes a splice region, synonymous change. The variant allele was found at a frequency of 0.0201 in 1,609,992 control chromosomes in the GnomAD database, including 394 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.017 ( 37 hom., cov: 32)
Exomes 𝑓: 0.020 ( 357 hom. )

Consequence

CFTR
NM_000492.4 splice_region, synonymous

Scores

3
Splicing: ADA: 0.9939
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:6B:16O:3

Conservation

PhyloP100: 6.38

Publications

39 publications found
Variant links:
Genes affected
CFTR (HGNC:1884): (CF transmembrane conductance regulator) This gene encodes a member of the ATP-binding cassette (ABC) transporter superfamily. The encoded protein functions as a chloride channel, making it unique among members of this protein family, and controls ion and water secretion and absorption in epithelial tissues. Channel activation is mediated by cycles of regulatory domain phosphorylation, ATP-binding by the nucleotide-binding domains, and ATP hydrolysis. Mutations in this gene cause cystic fibrosis, the most common lethal genetic disorder in populations of Northern European descent. The most frequently occurring mutation in cystic fibrosis, DeltaF508, results in impaired folding and trafficking of the encoded protein. Multiple pseudogenes have been identified in the human genome. [provided by RefSeq, Aug 2017]
CFTR-AS1 (HGNC:40144): (CFTR antisense RNA 1)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000492.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF. No scorers claiming Uncertain. Scorers claiming Benign: max_spliceai.
BP6
Variant 7-117559655-G-A is Benign according to our data. Variant chr7-117559655-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 43576.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.017 (2580/152136) while in subpopulation AMR AF = 0.0302 (462/15286). AF 95% confidence interval is 0.0279. There are 37 homozygotes in GnomAd4. There are 1239 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 37 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000492.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CFTR
NM_000492.4
MANE Select
c.1584G>Ap.Glu528Glu
splice_region synonymous
Exon 11 of 27NP_000483.3
CFTR-AS1
NR_149084.1
n.221+1078C>T
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CFTR
ENST00000003084.11
TSL:1 MANE Select
c.1584G>Ap.Glu528Glu
splice_region synonymous
Exon 11 of 27ENSP00000003084.6P13569-1
CFTR
ENST00000699602.1
c.1584G>Ap.Glu528Glu
splice_region synonymous
Exon 11 of 27ENSP00000514471.1A0A8V8TNH2
CFTR
ENST00000889206.1
c.1584G>Ap.Glu528Glu
splice_region synonymous
Exon 11 of 26ENSP00000559265.1

Frequencies

GnomAD3 genomes
AF:
0.0170
AC:
2581
AN:
152020
Hom.:
37
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00435
Gnomad AMI
AF:
0.0308
Gnomad AMR
AF:
0.0303
Gnomad ASJ
AF:
0.00260
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00332
Gnomad FIN
AF:
0.0240
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0234
Gnomad OTH
AF:
0.0192
GnomAD2 exomes
AF:
0.0167
AC:
4190
AN:
250582
AF XY:
0.0166
show subpopulations
Gnomad AFR exome
AF:
0.00462
Gnomad AMR exome
AF:
0.0187
Gnomad ASJ exome
AF:
0.00199
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0238
Gnomad NFE exome
AF:
0.0241
Gnomad OTH exome
AF:
0.0203
GnomAD4 exome
AF:
0.0204
AC:
29752
AN:
1457856
Hom.:
357
Cov.:
29
AF XY:
0.0200
AC XY:
14522
AN XY:
725568
show subpopulations
African (AFR)
AF:
0.00315
AC:
105
AN:
33380
American (AMR)
AF:
0.0190
AC:
848
AN:
44692
Ashkenazi Jewish (ASJ)
AF:
0.00222
AC:
58
AN:
26110
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39596
South Asian (SAS)
AF:
0.00316
AC:
272
AN:
86156
European-Finnish (FIN)
AF:
0.0239
AC:
1266
AN:
53018
Middle Eastern (MID)
AF:
0.00713
AC:
41
AN:
5748
European-Non Finnish (NFE)
AF:
0.0236
AC:
26215
AN:
1108884
Other (OTH)
AF:
0.0157
AC:
947
AN:
60272
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
1223
2447
3670
4894
6117
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
946
1892
2838
3784
4730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0170
AC:
2580
AN:
152136
Hom.:
37
Cov.:
32
AF XY:
0.0167
AC XY:
1239
AN XY:
74370
show subpopulations
African (AFR)
AF:
0.00433
AC:
180
AN:
41534
American (AMR)
AF:
0.0302
AC:
462
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00260
AC:
9
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5182
South Asian (SAS)
AF:
0.00332
AC:
16
AN:
4820
European-Finnish (FIN)
AF:
0.0240
AC:
254
AN:
10578
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0234
AC:
1588
AN:
67954
Other (OTH)
AF:
0.0190
AC:
40
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
125
250
376
501
626
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0197
Hom.:
137
Bravo
AF:
0.0165
Asia WGS
AF:
0.00202
AC:
7
AN:
3476
EpiCase
AF:
0.0220
EpiControl
AF:
0.0213

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
5
Cystic fibrosis (7)
-
1
5
not provided (6)
-
1
3
CFTR-related disorder (4)
-
-
2
not specified (3)
-
1
-
Bronchiectasis with or without elevated sweat chloride 1 (1)
-
1
-
Congenital bilateral aplasia of vas deferens from CFTR mutation (1)
-
-
1
Hereditary pancreatitis (2)
-
-
-
Pancreatitis (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.23
CADD
Benign
23
DANN
Benign
0.89
PhyloP100
6.4
Mutation Taster
=12/88
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
0.99
dbscSNV1_RF
Pathogenic
0.98
Splicevardb
3.0
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs1800095;
hg19: chr7-117199709;
COSMIC: COSV50089416;
COSMIC: COSV50089416;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.